Research Specialist in Cancer Genomics to Integrate Basic Research and Clinical Data

NIH RePORTER · NIH · R50 · $112,973 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Human cancers are complex diseases with pathobiology driven by heritable genetics, environmental exposures, somatic genomic and epigenomic alterations, and contributions for immunological and other responses in the host micro- and macroenvironment. Cancer therapeutics overlay another dimension with respect to particular vulnerabilities that underly concepts of precision medicine. Currently, integrating genome-scale data from mechanistic ‘cause-effect’ laboratory-based studies to the pathobiology of in vivo tumors in the context of clinical care remains challenging. This proposal is designed to provide support for a highly skilled and productive scientist with expertise across laboratory, bioinformatics, and clinical medicine. The objectives are (i) to provide biostatistical and bioinformatics skills for a range of program investigators that seek to bi-directional integration for the development and testing of hypotheses involving cancer genomics; (ii) to develop new approaches (modeling and computational tools) for the analyses and integration of genome-scale data; and (iii) apply rigor and reproducibility in data annotation for submission/sharing of program genomics data to the research community.

Key facts

NIH application ID
10899604
Project number
5R50CA274336-02
Recipient
FRED HUTCHINSON CANCER CENTER
Principal Investigator
ILSA COLEMAN
Activity code
R50
Funding institute
NIH
Fiscal year
2024
Award amount
$112,973
Award type
5
Project period
2023-08-15 → 2028-07-31